Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 124

1.

Recent Advances in the Medicinal Chemistry of Liver X Receptors.

El-Gendy BEM, Goher SS, Hegazy LS, Arief MMH, Burris TP.

J Med Chem. 2018 Jul 30. doi: 10.1021/acs.jmedchem.8b00045. [Epub ahead of print]

PMID:
30004226
2.

Corrigendum to "Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain" [GENE 655 (2018) 1-12].

Das V, Kc R, Li X, Varma D, Qiu S, Kroin JS, Forsyth CB, Keshavarzian A, van Wijnen AJ, Park TJ, Stein GS, O-Sullivan I, Burris TP, Im HJ.

Gene. 2018 Jun 12. pii: S0378-1119(18)30662-0. doi: 10.1016/j.gene.2018.06.013. [Epub ahead of print] No abstract available.

PMID:
29890121
3.

Distinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle.

Amador A, Campbell S, Kazantzis M, Lan G, Burris TP, Solt LA.

PLoS One. 2018 May 3;13(5):e0196787. doi: 10.1371/journal.pone.0196787. eCollection 2018.

4.

Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain.

Das V, Kc R, Li X, Varma D, Qiu S, Kroin JS, Forsyth CB, Keshavarzian A, van Wijnen AJ, Park TJ, Stein GS, O-Sullivan I, Burris TP, Im HJ.

Gene. 2018 May 20;655:1-12. doi: 10.1016/j.gene.2018.02.048. Epub 2018 Feb 20. Erratum in: Gene. 2018 Jun 12;:.

PMID:
29474860
5.

REV-ERBβ is required to maintain normal wakefulness and the wake-inducing effect of dual REV-ERB agonist SR9009.

Amador A, Kamenecka TM, Solt LA, Burris TP.

Biochem Pharmacol. 2018 Apr;150:1-8. doi: 10.1016/j.bcp.2018.01.009. Epub 2018 Jan 23.

PMID:
29355503
6.

Adropin: An endocrine link between the biological clock and cholesterol homeostasis.

Ghoshal S, Stevens JR, Billon C, Girardet C, Sitaula S, Leon AS, Rao DC, Skinner JS, Rankinen T, Bouchard C, Nuñez MV, Stanhope KL, Howatt DA, Daugherty A, Zhang J, Schuelke M, Weiss EP, Coffey AR, Bennett BJ, Sethupathy P, Burris TP, Havel PJ, Butler AA.

Mol Metab. 2018 Feb;8:51-64. doi: 10.1016/j.molmet.2017.12.002. Epub 2017 Dec 30.

7.

Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.

Pourcet B, Zecchin M, Ferri L, Beauchamp J, Sitaula S, Billon C, Delhaye S, Vanhoutte J, Mayeuf-Louchart A, Thorel Q, Haas JT, Eeckhoute J, Dombrowicz D, Duhem C, Boulinguiez A, Lancel S, Sebti Y, Burris TP, Staels B, Duez HM.

Gastroenterology. 2018 Apr;154(5):1449-1464.e20. doi: 10.1053/j.gastro.2017.12.019. Epub 2017 Dec 24.

8.

Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle.

Welch RD, Billon C, Valfort AC, Burris TP, Flaveny CA.

Sci Rep. 2017 Dec 7;7(1):17142. doi: 10.1038/s41598-017-17496-7.

9.

REV-ERBα ameliorates heart failure through transcription repression.

Zhang L, Zhang R, Tien CL, Chan RE, Sugi K, Fu C, Griffin AC, Shen Y, Burris TP, Liao X, Jain MK.

JCI Insight. 2017 Sep 7;2(17). pii: 95177. doi: 10.1172/jci.insight.95177. [Epub ahead of print]

10.

Metabolic Characterization of a Novel RORα Knockout Mouse Model without Ataxia.

Billon C, Sitaula S, Burris TP.

Front Endocrinol (Lausanne). 2017 Jul 11;8:141. doi: 10.3389/fendo.2017.00141. eCollection 2017.

11.

Rev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistrome.

Welch RD, Guo C, Sengupta M, Carpenter KJ, Stephens NA, Arnett SA, Meyers MJ, Sparks LM, Smith SR, Zhang J, Burris TP, Flaveny CA.

Mol Metab. 2017 May 19;6(7):703-714. doi: 10.1016/j.molmet.2017.05.001. eCollection 2017 Jul.

12.

Oral IL-10 suppresses colon carcinogenesis via elimination of pathogenicCD4+ T-cells and induction of antitumor CD8+ T-cell activity.

Gu T, De Jesus M, Gallagher HC, Burris TP, Egilmez NK.

Oncoimmunology. 2017 Apr 20;6(6):e1319027. doi: 10.1080/2162402X.2017.1319027. eCollection 2017.

13.

Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model.

Zhang Q, Liu S, Ge D, Cunningham DM, Huang F, Ma L, Burris TP, You Z.

Prostate. 2017 Jun;77(8):888-899. doi: 10.1002/pros.23343. Epub 2017 Feb 27.

14.

Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease.

Alibhai FJ, LaMarre J, Reitz CJ, Tsimakouridze EV, Kroetsch JT, Bolz SS, Shulman A, Steinberg S, Burris TP, Oudit GY, Martino TA.

J Mol Cell Cardiol. 2017 Apr;105:24-37. doi: 10.1016/j.yjmcc.2017.01.008. Epub 2017 Feb 20.

15.

Rev-erb regulation of cholesterologenesis.

Sitaula S, Zhang J, Ruiz F, Burris TP.

Biochem Pharmacol. 2017 May 1;131:68-77. doi: 10.1016/j.bcp.2017.02.006. Epub 2017 Feb 15.

PMID:
28213272
16.

Nuclear receptors: PPARα ligands make memories.

Burris TP.

Nat Chem Biol. 2016 Nov 15;12(12):993-994. doi: 10.1038/nchembio.2241. No abstract available.

PMID:
27846207
17.

Inhibition of RORα/γ suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation.

Billon C, Sitaula S, Burris TP.

Mol Metab. 2016 Jul 25;5(10):997-1005. doi: 10.1016/j.molmet.2016.07.001. eCollection 2016 Oct.

18.

Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease.

Griffett K, Burris TP.

Biochem Biophys Res Commun. 2016 Oct 21;479(3):424-428. doi: 10.1016/j.bbrc.2016.09.036. Epub 2016 Sep 25.

19.

Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation.

Amador A, Huitron-Resendiz S, Roberts AJ, Kamenecka TM, Solt LA, Burris TP.

PLoS One. 2016 Sep 7;11(9):e0162452. doi: 10.1371/journal.pone.0162452. eCollection 2016.

20.

Correction: Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression.

Amador A, Wang Y, Banerjee S, Kamenecka TM, Solt LA, Burris TP.

PLoS One. 2016 May 19;11(5):e0156367. doi: 10.1371/journal.pone.0156367. eCollection 2016.

Supplemental Content

Loading ...
Support Center